Trauma and Dementia
- Conditions
- Psychiatric disorders and behavioral problemsPost Traumatic Stress DisorderPTSD in dementia10012272
- Registration Number
- NL-OMON52695
- Lead Sponsor
- niversiteit Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 148
Study A:
To investigate, feasibility, reliability and validity (sensitivity and
specificity) of the TRADE-interview, we include all patients with dementia
(major neurocognitive disorder according to DSM-5 : Alzheimer*s disease,
vascular dementia, frontotemporal dementia, lewy-body dementia, other specified
dementia) receiving care from Mondriaan or Cicero-zorggroep, Meandergroep
Envida or Sevagram, Zuyderland. Patients and legal representative have to give
informed consent.
Study B:
In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
-Clinical diagnoses according to DSM-5 with: major neurocognitive disorder,
dementia (Alzheimer*s disease, vascular dementia, frontotemporal dementia,
lewy-body dementia, other specified dementia).
-Patients with a positive life report of traumatic life events and symptoms of
PTSD and eligible for psychiatric treatment according to routine clinical
standards (according to clinical psychiatric evaluation by a psychiatrist or
psychologist).
-Intention to be treated and participate with treatment (including
legal representative).
-Written informed consent (including legal representative and
informant).
Study A:
- Subjects who do not have a family member or concerned caregiver who can
deliver informant information are excluded from the study.
- Subjects who are severely demented and impaired in their verbal
communication: Based on the model of Verdult & van der Kooij on
experience-based care, subjects in phase 3 and 4 will be excluded (Finnema
2015).
- Subject who are expected to give resistance, based on their daily care
experience.
-Major medical or psychiatric conditions that may interfere with the study
procedures, e.g. deafness, severe psychotic conditions.
-Any other condition which in the opinion of the (co-) investigator might
interfere with the evaluation of the study objectives: unpredictable aggressive
outbursts which may threaten the investigator*s safety, serious physical
condition that makes it estimated that participation will be too burdened.
- Language barrier.
Study B:
A potential subject who meets any of the following criteria will be excluded
from participation in this study:
- Subjects who do not have a family member or concerned caregiver who can
deliver informant information are excluded from the study.
- Subjects who are severely demented and impaired in their verbal
communication: Based on the model of Verdult & van der Kooij on
experience-based care, subjects in phase 3 and 4 will be excluded (Finnema
2015).
- Subject who are expected to give resistance, based on their daily care
experience.
-Major medical or psychiatric conditions that may interfere with the study
procedures, e.g. deafness, severe psychotic conditions.
-Any other condition which in the opinion of the (co-) investigator might
interfere with the evaluation of the study objectives: unpredictable aggressive
outbursts which may threaten the investigator*s safety, serious physical
condition that makes it estimated that participation will be too burdened.
- Language barrier.
- Active drug abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method